Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
Strongbridge Biopharma
|
| gptkbp:CEO |
Paul R. Edick
|
| gptkbp:developedBy |
ready-to-use injectable and infusible drug formulations
|
| gptkbp:focusesOn |
neurology
endocrinology |
| gptkbp:foundedYear |
2005
|
| gptkbp:founder |
Steven Prestrelski
|
| gptkbp:headquartersLocation |
gptkb:Chicago,_Illinois,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Xeris Pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Keveyis
Gvoke Recorlev |
| gptkbp:stockSymbol |
XERS
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:website |
https://www.xerispharma.com/
|
| gptkbp:bfsParent |
gptkb:Mark_Thierer
|
| gptkbp:bfsLayer |
7
|